Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts.

ABSTRACT:

Importance

Serious injection-related infections (SIRIs) cause significant morbidity and mortality. Medication for opioid use disorder (MOUD) improves outcomes but is underused. Understanding MOUD treatment after SIRIs could inform interventions to close this gap.

Objectives

To examine rehospitalization, death rates, and MOUD receipt for individuals with SIRIs and to assess characteristics associated with MOUD receipt.

Design, setting, and participants

This retrospective cohort study used the Massachusetts Public Health Data Warehouse, which included all individuals with a claim in the All-Payer Claims Database and is linked to individual-level data from multiple government agencies, to assess individuals aged 18 to 64 years with opioid use disorder and hospitalization

SUBMITTER: Kimmel SD 

PROVIDER: S-EPMC11270137 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature